[Effect of electronic moxibustion on memory function in patients with amnestic mild cognitive impairment]

Qi-Qi Liu1, Shang-Jie Chen1, Guo-Ming Shen2

  • 1Graduate School, Anhui University of CM, Hefei 230038, China; Department of Rehabilitation Medicine, Shenzhen Baoan Hospital Affiliated to Southern Medical University, Shenzhen 518101, Guangdong Province.

Abstract

Insights

Electronic moxibustion significantly improved memory and cognitive function in patients with amnestic mild cognitive impairment (aMCI). This therapy offers a promising non-pharmacological approach for managing aMCI symptoms.

Area of Science:

  • Neurology
  • Gerontology
  • Integrative Medicine

Background:

  • Amnestic mild cognitive impairment (aMCI) is characterized by memory deficits.
  • Current treatments for aMCI have limitations.
  • Non-pharmacological interventions are being explored to improve cognitive function.

Purpose of the Study:

  • To evaluate the efficacy of electronic moxibustion on memory function in aMCI patients.
  • To compare electronic moxibustion with placebo moxibustion.

Main Methods:

  • 59 aMCI patients were randomized into electronic moxibustion (30) and placebo (29) groups.
  • Treatments were administered over 4 weeks, with 2 courses.
  • Memory and cognitive functions were assessed using RBMT, N-back task, MMSE, and MoCA.

Main Results:

  • Electronic moxibustion group showed significant improvements in RBMT, N-back accuracy, MMSE, MoCA, immediate memory, and delayed recall (P<0.01).
  • Placebo group showed improvements in 1-back/2-back accuracy, immediate memory, and delayed recall (P<0.05, P<0.01).
  • Improvements in RBMT, N-back task, MMSE, and MoCA were significantly greater in the electronic moxibustion group than the placebo group (P<0.05).

Conclusions:

  • Electronic moxibustion demonstrates a significant positive effect on improving memory function in individuals with aMCI.
  • The findings suggest electronic moxibustion is a viable therapeutic option for enhancing cognitive performance in aMCI.

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
451
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.3K
Amnesia01:13

Amnesia

Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
356